Kumar Sravan Emany, SVP at Ironwood Pharmaceuticals (NASDAQ:IRWD), reported a large insider buy on September 18, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Emany purchased 36,072 shares of Ironwood Pharmaceuticals. The total transaction amounted to $300,119.
Ironwood Pharmaceuticals shares are trading up 10.16% at $9.48 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to ...